| Aloha Nursing & Rehab Centre | |
| 45-545 Kamehameha Highway, Kaneohe, Hawaii 96744 | |
| (808) 247-2220 | |
| Name | Aloha Nursing & Rehab Centre |
|---|---|
| Location | 45-545 Kamehameha Highway, Kaneohe, Hawaii |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 141 |
| Occupancy Rate | 74.96% |
| Medicare ID (CCN) | 125038 |
| Legal Business Name | Island Health Care Limited Partnership |
| Ownership Type | For Profit - Partnership |
| NPI Number | 1124026901 |
| Organization Name | ISLAND HEALTH CARE LIMITED PARTNERSHIP |
| Doing Business As | ALOHA NURSING REHAB CENTRE |
| Address | 45-545 Kamehameha Hwy, Kaneohe, HI 96744 |
| Phone Number | 808-247-2220 |
News Archive
Excelsior Medical Corporation announced today that it has received FDA 510(k) clearance for SwabFlush™, its latest product for the vascular access and infection control markets.
TRS Institute (TRSI), the nation's leading provider of AHDI-approved online medical transcription and speech recognition training programs, announces an exclusive partnership with ScribeAmerica, the nation's pioneer in medical scribe training and management. The two organizations will combine and leverage training expertise to deliver an affordable self-study, self-paced online training program for Medical Scribes.
Advances in microscopy techniques have often triggered important discoveries in the field of neuroscience, enabling vital insights in understanding the brain and promising new treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces that the US Food and Drug Administration (FDA) considers the positive results of the pivotal phase III study with acyclovir Lauriad acceptable to submit a 505(b)(2) New Drug Application of the product in the United States.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Excelsior Medical Corporation announced today that it has received FDA 510(k) clearance for SwabFlush™, its latest product for the vascular access and infection control markets.
TRS Institute (TRSI), the nation's leading provider of AHDI-approved online medical transcription and speech recognition training programs, announces an exclusive partnership with ScribeAmerica, the nation's pioneer in medical scribe training and management. The two organizations will combine and leverage training expertise to deliver an affordable self-study, self-paced online training program for Medical Scribes.
Advances in microscopy techniques have often triggered important discoveries in the field of neuroscience, enabling vital insights in understanding the brain and promising new treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces that the US Food and Drug Administration (FDA) considers the positive results of the pivotal phase III study with acyclovir Lauriad acceptable to submit a 505(b)(2) New Drug Application of the product in the United States.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $9750 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.21 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.78 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.74 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.79 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.57 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.98 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.56 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.82 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.15 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 73.12 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.28 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.61 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.1 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.26 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.07 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 65.17 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 80 | 82.93 |
News Archive
Excelsior Medical Corporation announced today that it has received FDA 510(k) clearance for SwabFlush™, its latest product for the vascular access and infection control markets.
TRS Institute (TRSI), the nation's leading provider of AHDI-approved online medical transcription and speech recognition training programs, announces an exclusive partnership with ScribeAmerica, the nation's pioneer in medical scribe training and management. The two organizations will combine and leverage training expertise to deliver an affordable self-study, self-paced online training program for Medical Scribes.
Advances in microscopy techniques have often triggered important discoveries in the field of neuroscience, enabling vital insights in understanding the brain and promising new treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces that the US Food and Drug Administration (FDA) considers the positive results of the pivotal phase III study with acyclovir Lauriad acceptable to submit a 505(b)(2) New Drug Application of the product in the United States.
› Verified 8 days ago
Harry And Jeanette Weinberg Care Center Location: 45-090 Namoku St, Kaneohe, Hawaii 96744 Phone: (808) 247-1670 | |
Aloha Nursing & Rehab Centre Location: 45-545 Kamehameha Highway, Kaneohe, Hawaii 96744 Phone: (808) 247-2220 | |
Ann Pearl Nursing Facility Location: 45-181 Waikalua Road, Kaneohe, Hawaii 96744 Phone: (808) 247-8558 |